A1 Orlando Medical Corporation Consolidated Statements of Financial Position 1 December 31, 3 (In Millions) 2018 2017 Assets: Current Assets Cash and cash equivalents Short-term investments Accounts and notes receivable Inventories, at cost Prepaid expense and other current assets Total current assets $ 4,226 $ 4,333 845 6. 520 8. 3,400 433 2,403 411 1,226 10 1,638 10,649 1,555 6,804 303 $ 19,311 11 8,786 907 5,199 155 $ 15,047 12 Property and equipment, net 14 Other non-current assets 15 Total assets 16 Liabilities and stockholders' equity: Current liabilities Accounts payable Accrued and other liabilities 17 18 19 $ 7,708 3,676 11,384 304 1.701 13,389 $ 6,009 3,033 9,042 305 1.179 10,526 Total current liabilities 20 21 Long-term debt Other non-current liabilities 23 Total liabilities 24 Stockholders' equity 22 Preferred stock and capital in excess of $0.02 par value; 25 shares issued and outstanding: none Common stock and capital in excess of S0.05 par value; 28 26 27 shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost: 183 and 123 shares, respectively 29 7,803 (6,444) 4,676 (79) (34) 5,922 $ 19,311 7,001 (4,401) 1,990 (25) (44) 4,521 $ 15,047 30 31 Retained earnings 32 Other comprehensive loss 33 Other 34 Total stockholders' equity 35 Total liabilities and stockholders' equity 36 A1 Orlando Medical Corporation Consolidated Statements of Income 2 Year ended December 31, 3 (In Millions, Except per Share Amounts) 4 Net Revenue 5 Cost of goods sold 2018 $ 42,666 35,147 7,519 2016 $ 31,111 25,492 5,619 2017 $ 35,220 29,255 5,965 Gross profit 7 Operating expenses: 8. 6. Selling, general, and administrative Research, development, and engineering 10 3,341 544 3,250 553 2,985 536 512 4,033 1,586 (30) 1,556 472 $ 1.084 Special charges Total operating expenses. Operating income 11 12 13 Investment and other income (loss), net 14 3,885 3,634 153 3,787 1.136 $ 2,651 3,803 2,162 196 2,358 940 $ 1.418 Income before income taxes 15 Income tax expense 16 Net income 17 Earnings per common share: Basic 19 1.41 0.95 $ 0.37
A1 Orlando Medical Corporation Consolidated Statements of Financial Position 1 December 31, 3 (In Millions) 2018 2017 Assets: Current Assets Cash and cash equivalents Short-term investments Accounts and notes receivable Inventories, at cost Prepaid expense and other current assets Total current assets $ 4,226 $ 4,333 845 6. 520 8. 3,400 433 2,403 411 1,226 10 1,638 10,649 1,555 6,804 303 $ 19,311 11 8,786 907 5,199 155 $ 15,047 12 Property and equipment, net 14 Other non-current assets 15 Total assets 16 Liabilities and stockholders' equity: Current liabilities Accounts payable Accrued and other liabilities 17 18 19 $ 7,708 3,676 11,384 304 1.701 13,389 $ 6,009 3,033 9,042 305 1.179 10,526 Total current liabilities 20 21 Long-term debt Other non-current liabilities 23 Total liabilities 24 Stockholders' equity 22 Preferred stock and capital in excess of $0.02 par value; 25 shares issued and outstanding: none Common stock and capital in excess of S0.05 par value; 28 26 27 shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost: 183 and 123 shares, respectively 29 7,803 (6,444) 4,676 (79) (34) 5,922 $ 19,311 7,001 (4,401) 1,990 (25) (44) 4,521 $ 15,047 30 31 Retained earnings 32 Other comprehensive loss 33 Other 34 Total stockholders' equity 35 Total liabilities and stockholders' equity 36 A1 Orlando Medical Corporation Consolidated Statements of Income 2 Year ended December 31, 3 (In Millions, Except per Share Amounts) 4 Net Revenue 5 Cost of goods sold 2018 $ 42,666 35,147 7,519 2016 $ 31,111 25,492 5,619 2017 $ 35,220 29,255 5,965 Gross profit 7 Operating expenses: 8. 6. Selling, general, and administrative Research, development, and engineering 10 3,341 544 3,250 553 2,985 536 512 4,033 1,586 (30) 1,556 472 $ 1.084 Special charges Total operating expenses. Operating income 11 12 13 Investment and other income (loss), net 14 3,885 3,634 153 3,787 1.136 $ 2,651 3,803 2,162 196 2,358 940 $ 1.418 Income before income taxes 15 Income tax expense 16 Net income 17 Earnings per common share: Basic 19 1.41 0.95 $ 0.37
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
Related questions
Question
Orlando Medical’s long-term debt carries an annual interest rate of 11%. During the
year ended December 31, 2018, Orlando’s times-interest-earned ratio was
a. 137.9 times.
b. $35,147.
c. 20.1 times.
d. 108.7 times.
![A1
Orlando Medical Corporation
Consolidated Statements of Financial Position
1
December 31,
3 (In Millions)
2018
2017
Assets:
Current Assets
Cash and cash equivalents
Short-term investments
Accounts and notes receivable
Inventories, at cost
Prepaid expense and other current assets
Total current assets
$ 4,226
$ 4,333
845
6.
520
8.
3,400
433
2,403
411
1,226
10
1,638
10,649
1,555
6,804
303
$ 19,311
11
8,786
907
5,199
155
$ 15,047
12 Property and equipment, net
14 Other non-current assets
15 Total assets
16 Liabilities and stockholders' equity:
Current liabilities
Accounts payable
Accrued and other liabilities
17
18
19
$ 7,708
3,676
11,384
304
1.701
13,389
$ 6,009
3,033
9,042
305
1.179
10,526
Total current liabilities
20
21
Long-term debt
Other non-current liabilities
23 Total liabilities
24 Stockholders' equity
22
Preferred stock and capital in excess of $0.02 par value;
25
shares issued and outstanding: none
Common stock and capital in excess of S0.05 par value;
28
26
27
shares authorized: 6,000; shares issued: 2,163 and
1,903, respectively
Treasury stock, at cost: 183 and 123 shares, respectively
29
7,803
(6,444)
4,676
(79)
(34)
5,922
$ 19,311
7,001
(4,401)
1,990
(25)
(44)
4,521
$ 15,047
30
31
Retained earnings
32
Other comprehensive loss
33
Other
34 Total stockholders' equity
35 Total liabilities and stockholders' equity
36
A1
Orlando Medical Corporation
Consolidated Statements of Income
2
Year ended December 31,
3 (In Millions, Except per Share Amounts)
4 Net Revenue
5 Cost of goods sold
2018
$ 42,666
35,147
7,519
2016
$ 31,111
25,492
5,619
2017
$ 35,220
29,255
5,965
Gross profit
7 Operating expenses:
8.
6.
Selling, general, and administrative
Research, development, and engineering
10
3,341
544
3,250
553
2,985
536
512
4,033
1,586
(30)
1,556
472
$ 1.084
Special charges
Total operating expenses.
Operating income
11
12
13 Investment and other income (loss), net
14
3,885
3,634
153
3,787
1.136
$ 2,651
3,803
2,162
196
2,358
940
$ 1.418
Income before income taxes
15 Income tax expense
16
Net income
17 Earnings per common share:
Basic
19
1.41
0.95
$ 0.37](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F00fdef95-b35d-4b7d-801a-438456b13d6f%2F448467bb-18be-4a4c-9637-d4e831d6e541%2Foy7gerc.png&w=3840&q=75)
Transcribed Image Text:A1
Orlando Medical Corporation
Consolidated Statements of Financial Position
1
December 31,
3 (In Millions)
2018
2017
Assets:
Current Assets
Cash and cash equivalents
Short-term investments
Accounts and notes receivable
Inventories, at cost
Prepaid expense and other current assets
Total current assets
$ 4,226
$ 4,333
845
6.
520
8.
3,400
433
2,403
411
1,226
10
1,638
10,649
1,555
6,804
303
$ 19,311
11
8,786
907
5,199
155
$ 15,047
12 Property and equipment, net
14 Other non-current assets
15 Total assets
16 Liabilities and stockholders' equity:
Current liabilities
Accounts payable
Accrued and other liabilities
17
18
19
$ 7,708
3,676
11,384
304
1.701
13,389
$ 6,009
3,033
9,042
305
1.179
10,526
Total current liabilities
20
21
Long-term debt
Other non-current liabilities
23 Total liabilities
24 Stockholders' equity
22
Preferred stock and capital in excess of $0.02 par value;
25
shares issued and outstanding: none
Common stock and capital in excess of S0.05 par value;
28
26
27
shares authorized: 6,000; shares issued: 2,163 and
1,903, respectively
Treasury stock, at cost: 183 and 123 shares, respectively
29
7,803
(6,444)
4,676
(79)
(34)
5,922
$ 19,311
7,001
(4,401)
1,990
(25)
(44)
4,521
$ 15,047
30
31
Retained earnings
32
Other comprehensive loss
33
Other
34 Total stockholders' equity
35 Total liabilities and stockholders' equity
36
A1
Orlando Medical Corporation
Consolidated Statements of Income
2
Year ended December 31,
3 (In Millions, Except per Share Amounts)
4 Net Revenue
5 Cost of goods sold
2018
$ 42,666
35,147
7,519
2016
$ 31,111
25,492
5,619
2017
$ 35,220
29,255
5,965
Gross profit
7 Operating expenses:
8.
6.
Selling, general, and administrative
Research, development, and engineering
10
3,341
544
3,250
553
2,985
536
512
4,033
1,586
(30)
1,556
472
$ 1.084
Special charges
Total operating expenses.
Operating income
11
12
13 Investment and other income (loss), net
14
3,885
3,634
153
3,787
1.136
$ 2,651
3,803
2,162
196
2,358
940
$ 1.418
Income before income taxes
15 Income tax expense
16
Net income
17 Earnings per common share:
Basic
19
1.41
0.95
$ 0.37
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 4 steps with 3 images
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![Horngren's Cost Accounting: A Managerial Emphasis…](https://www.bartleby.com/isbn_cover_images/9780134475585/9780134475585_smallCoverImage.gif)
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
![Intermediate Accounting](https://www.bartleby.com/isbn_cover_images/9781259722660/9781259722660_smallCoverImage.gif)
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
![Financial and Managerial Accounting](https://www.bartleby.com/isbn_cover_images/9781259726705/9781259726705_smallCoverImage.gif)
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education